Walleye Capital LLC Anavex Life Sciences Corp. Transaction History
Walleye Capital LLC
- $46.2 Billion
- Q3 2024
A detailed history of Walleye Capital LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Walleye Capital LLC holds 23,400 shares of AVXL stock, worth $207,557. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,400Holding current value
$207,557% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AVXL
# of Institutions
163Shares Held
26.6MCall Options Held
515KPut Options Held
838K-
Black Rock Inc. New York, NY6.39MShares$56.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.74MShares$42 Million0.0% of portfolio
-
State Street Corp Boston, MA3.07MShares$27.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$16.7 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA913KShares$8.1 Million0.62% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $691M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...